The Immunobiology of Prostanoid Receptor Signaling in Connecting Innate and Adaptive Immunity

Overview

Journal Biomed Res Int

Publisher Wiley

Specialties Biomedical Engineering
Biotechnology
General Medicine

Date 2013 Sep 12

PMID 24024207

Citations 24

Authors

Hedi Harizi

Affiliations

Soon will be listed here.

Abstract

Prostanoids, including prostaglandins (PGs), thromboxanes (TXs), and prostacyclins, are synthesized from arachidonic acid (AA) by the action of Cyclooxygenase (COX) enzymes. They are bioactive inflammatory lipid mediators that play a key role in immunity and immunopathology. Prostanoids exert their effects on immune and inflammatory cells by binding to membrane receptors that are widely expressed throughout the immune system and act at multiple levels in innate and adaptive immunity. The immunoregulatory role of prostanoids results from their ability to regulate cell-cell interaction, antigen presentation, cytokine production, cytokine receptor expression, differentiation, survival, apoptosis, cell-surface molecule levels, and cell migration in both autocrine and paracrine manners. By acting on immune cells of both systems, prostanoids and their receptors have great impact on immune regulation and play a pivotal role in connecting innate and adaptive immunity. This paper focuses on the immunobiology of prostanoid receptor signaling because of their potential clinical relevance for various disorders including inflammation, autoimmunity, and tumorigenesis. We mainly discuss the effects of major COX metabolites, PGD2, PGE2, their signaling during dendritic cell (DC)-natural killer (NK) reciprocal crosstalk, DC-T cell interaction, and subsequent consequences on determining crucial aspects of innate and adaptive immunity in normal and pathological settings.

Citing Articles

The role of immunomodulators in treatment-resistant depression: case studies.

Beckett C, Niklison-Chirou M Cell Death Discov. 2022; 8(1):367.

PMID: 35977923 PMC: 9385739. DOI: 10.1038/s41420-022-01147-6.

Immunomodulatory Effect of Polysaccharide from Fermented L. (Noni) on RAW 264.7 Macrophage and Balb/c Mice.

Choi S, La I, Han X, Men X, Lee S, Oh G Foods. 2022; 11(13).

PMID: 35804740 PMC: 9266266. DOI: 10.3390/foods11131925.

Characterization of prostanoids response to Bordetella pertussis antigen BscF and Tdap in LPS-challenged monocytes.

Raihan M, Espelien B, Hanson C, McGregor B, Velaris N, Alvine T Prostaglandins Leukot Essent Fatty Acids. 2022; 182:102452.

PMID: 35690004 PMC: 10211250. DOI: 10.1016/j.plefa.2022.102452.

Cyclooxygenase production of PGE2 promotes phagocyte control of A. fumigatus hyphal growth in larval zebrafish.

Thrikawala S, Niu M, Keller N, Rosowski E PLoS Pathog. 2022; 18(3):e1010040.

PMID: 35333905 PMC: 8986117. DOI: 10.1371/journal.ppat.1010040.

Modulation of Inflammatory Signaling Molecules in Antigen-Challenged Human Monocytes in Presence of Adrenergic Agonists.

Raihan M, Espelien B, McGregor B, Hanson C, Brishti A, Velaris N Vaccines (Basel). 2022; 10(2).

PMID: 35214778 PMC: 8879854. DOI: 10.3390/vaccines10020321.

References

Harizi H, Juzan M, Grosset C, Rashedi M, Gualde N . Dendritic cells issued in vitro from bone marrow produce PGE(2) that contributes to the immunomodulation induced by antigen-presenting cells. Cell Immunol. 2001; 209(1):19-28. DOI: 10.1006/cimm.2001.1785. View

Smyth G, Stapleton P, Barden C, Mestre J, Freeman T, Duff M . Renal cell carcinoma induces prostaglandin E2 and T-helper type 2 cytokine production in peripheral blood mononuclear cells. Ann Surg Oncol. 2003; 10(4):455-62. DOI: 10.1245/aso.2003.06.036. View

Steinbrink K, Wolfl M, Jonuleit H, Knop J, Enk A . Induction of tolerance by IL-10-treated dendritic cells. J Immunol. 1997; 159(10):4772-80. View

Holt D, Ma X, Kundu N, Fulton A . Prostaglandin E(2) (PGE (2)) suppresses natural killer cell function primarily through the PGE(2) receptor EP4. Cancer Immunol Immunother. 2011; 60(11):1577-86. PMC: 3686482. DOI: 10.1007/s00262-011-1064-9. View

Hida T, Yatabe Y, Achiwa H, Muramatsu H, Kozaki K, Nakamura S . Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res. 1998; 58(17):3761-4. View

Bhattacharya M, Peri K, Almazan G, Ribeiro-da-Silva A, Shichi H, Durocher Y . Nuclear localization of prostaglandin E2 receptors. Proc Natl Acad Sci U S A. 1998; 95(26):15792-7. PMC: 28123. DOI: 10.1073/pnas.95.26.15792. View

Harizi H, Gualde N . The impact of eicosanoids on the crosstalk between innate and adaptive immunity: the key roles of dendritic cells. Tissue Antigens. 2005; 65(6):507-14. DOI: 10.1111/j.1399-0039.2005.00394.x. View

Shimura C, Satoh T, Igawa K, Aritake K, Urade Y, Nakamura M . Dendritic cells express hematopoietic prostaglandin D synthase and function as a source of prostaglandin D2 in the skin. Am J Pathol. 2009; 176(1):227-37. PMC: 2797885. DOI: 10.2353/ajpath.2010.090111. View

Bell-Parikh L, Ide T, Lawson J, McNamara P, Reilly M, FitzGerald G . Biosynthesis of 15-deoxy-delta12,14-PGJ2 and the ligation of PPARgamma. J Clin Invest. 2003; 112(6):945-55. PMC: 193665. DOI: 10.1172/JCI18012. View

10.

Chen Y, Perussia B, Campbell K . Prostaglandin D2 suppresses human NK cell function via signaling through D prostanoid receptor. J Immunol. 2007; 179(5):2766-73. DOI: 10.4049/jimmunol.179.5.2766. View

11.

Theiner G, Gessner A, Lutz M . The mast cell mediator PGD2 suppresses IL-12 release by dendritic cells leading to Th2 polarized immune responses in vivo. Immunobiology. 2006; 211(6-8):463-72. DOI: 10.1016/j.imbio.2006.05.020. View

12.

Harizi H . Reciprocal crosstalk between dendritic cells and natural killer cells under the effects of PGE2 in immunity and immunopathology. Cell Mol Immunol. 2013; 10(3):213-21. PMC: 4012770. DOI: 10.1038/cmi.2013.1. View

13.

Troy A, Summers K, Davidson P, Atkinson C, Hart D . Minimal recruitment and activation of dendritic cells within renal cell carcinoma. Clin Cancer Res. 1998; 4(3):585-93. View

14.

Zaitsu M, Hamasaki Y, Matsuo M, Miyazaki M, Hayasaki R, Muro E . Induction of cytosolic phospholipase A2 and prostaglandin H2 synthase-2 by lipopolysaccharide in human polymorphonuclear leukocytes. Eur J Haematol. 1999; 63(2):94-102. DOI: 10.1111/j.1600-0609.1999.tb01122.x. View

15.

Jowsey I, Thomson A, Flanagan J, Murdock P, Moore G, Meyer D . Mammalian class Sigma glutathione S-transferases: catalytic properties and tissue-specific expression of human and rat GSH-dependent prostaglandin D2 synthases. Biochem J. 2001; 359(Pt 3):507-16. PMC: 1222171. DOI: 10.1042/0264-6021:3590507. View

16.

Legler D, Bruckner M, Uetz-von Allmen E, Krause P . Prostaglandin E2 at new glance: novel insights in functional diversity offer therapeutic chances. Int J Biochem Cell Biol. 2009; 42(2):198-201. DOI: 10.1016/j.biocel.2009.09.015. View

17.

Banchereau J, Steinman R . Dendritic cells and the control of immunity. Nature. 1998; 392(6673):245-52. DOI: 10.1038/32588. View

18.

Aderem A, Cohen D, Wright S, COHN Z . Bacterial lipopolysaccharides prime macrophages for enhanced release of arachidonic acid metabolites. J Exp Med. 1986; 164(1):165-79. PMC: 2188197. DOI: 10.1084/jem.164.1.165. View

19.

Enk A, Jonuleit H, Saloga J, Knop J . Dendritic cells as mediators of tumor-induced tolerance in metastatic melanoma. Int J Cancer. 1997; 73(3):309-16. DOI: 10.1002/(sici)1097-0215(19971104)73:3<309::aid-ijc1>3.0.co;2-3. View

20.

Fedyk E, Phipps R . Prostaglandin E2 receptors of the EP2 and EP4 subtypes regulate activation and differentiation of mouse B lymphocytes to IgE-secreting cells. Proc Natl Acad Sci U S A. 1996; 93(20):10978-83. PMC: 38269. DOI: 10.1073/pnas.93.20.10978. View